The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Novo Nordisk A/S said a bigger dose of the main ingredient in Wegovy, its top-selling weight-loss drug, helped patients shed ...

Novo Nordisk (NVO) announced Friday that a higher-dose version of its popular obesity therapy, semaglutide, marketed as ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

The European Union has a plan for dealing with increasing cyberattacks against hospitals in its member countries.

Man who shed 50 kg shares 3 things skinny people don’t understand about fat people: 'Weight loss isn't Nike commercial' ...

Here’s a roundup of some of the best fitness apps with January offers and sign-up deals to help you stay active and motivated ...

Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect prevalence and improving lean mass preservation and ...